Trial Profile
Clinical Trials Insight: 700044732
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 May 2009
Price :
$35
*
At a glance
- Drugs Iloperidone (Primary) ; Risperidone
- Indications Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions
- Sponsors Vanda Pharmaceuticals
- 20 May 2009 New trial record.